Mark Pogson is currently the Senior Director at Regeneron, a position they have held since 2024. They previously served in various roles, including Principal Scientist and Director in Oncology Research at bluebird bio from 2017 to 2021, where they led cross-functional teams and managed external partnerships. Mark's experience also includes postdoctoral fellowships at ETH Zurich and the University of Texas at Austin, where they conducted significant research in immune cell engineering and antibody development. Earlier in their career, they worked as a Senior Associate at Amgen and as a Research Associate at Immunex, focusing on protein purification and characterization. Mark earned a Ph.D. in Cell and Molecular Biology from the University of Texas at Austin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices